Market & News

Registered Office: 805 Dwarkesh Complex,RC Dutt Road Alkapuri, Vadodara - 390007, Gujarat, India.
Phone : 91-265-2332018   Fax:
Email :  cs.sanket@pardrugs.com  
Website :  www.pardrugs.com

Initial public offer consisiting of fresh issue of 16,72,000 equity shares of face value of Rs. 10 each fully paid of Par Drugs and Chemicals Limited ("The Issuer" or "The Company") for cash at a price of Rs. 51 per equity share (including a share premium of Rs. 41 per Equity share) (the "Issue Price") aggregating Rs. 8.53 crores (The "Issue") of which 84,000 equity shares of face value Rs. 10 each for Cash at a price of Rs. 51 per equity share, aggregating Rs. 0.43 crores will be reserved for subscription by the market maker to the Issue (The "Market Maker reservation portion") and 30,000 equity shares of face value Rs. 10 each for cash at a price of Rs. 51 per Equity share, aggregating upto Rs. 0.15 crores will be reserved for subscription by eligible employees (As defined) which constitute 0.49% of the post-issue paid-up equity share capital ("Employee Reservation Portion"). The issue less market maker reservation portion and employee reservation portion i.e. Issue 15,58,000 equity shares of face value of Rs. 10 each for cash at a price of Rs. 51 per equity share is hereinafter referred to as the "net issue". The issue and the net issue will constitute 27.18% and 25.32%, respectively of the fully Diluted post issue paid up equity share capital of the company. The face value of the equity shares is Rs. 10 each and the issue price of Rs. 51 is 5.1 times of the face value of the equity shares. Minimum application of 2000 equity shares and in multiples of 2000 equity shares thereafter.